Recombinant Paenibacillus polymyxa Lantibiotic paenibacillin

What is Paenibacillus polymyxa and why is paenibacillin significant for antimicrobial research?

Paenibacillus polymyxa is a Gram-positive, spore-forming bacterium that has been isolated from various environments including fermented foods and clinical samples . The strain P. polymyxa OSY-DF is particularly noteworthy for its unique ability to concurrently produce two distinct antimicrobial compounds: polymyxin E1, which is active against Gram-negative bacteria, and paenibacillin, a novel lantibiotic effective against Gram-positive bacteria . This dual production capability has not been previously reported in the scientific literature and represents a distinctive characteristic of this strain . Paenibacillin is significant in antimicrobial research because it demonstrates a broad spectrum of activity against food-borne pathogenic and spoilage bacteria, including Bacillus species, Clostridium sporogenes, Lactobacillus species, Listeria species, and Staphylococcus aureus, among others . Furthermore, it possesses ideal physicochemical properties for an antimicrobial agent, including water solubility, thermal resistance, and stability across a wide pH range (2.0 to 9.0), making it potentially valuable for various applications in food safety and medical fields .

What is the molecular structure and biochemical classification of paenibacillin?

Paenibacillin is a peptide with a molecular mass of 2,983 Da that has been characterized as a novel lantibiotic, which belongs to the class I bacteriocins . Lantibiotics are ribosomally synthesized peptides that undergo extensive post-translational modifications, resulting in the formation of unusual amino acids and thioether bridges that contribute to their stability and antimicrobial activity . The structural analysis of paenibacillin has been conducted using several sophisticated techniques, including Edman degradation, mass spectrometry, and nuclear magnetic resonance spectroscopy . These analyses have revealed that paenibacillin contains a high degree of post-translational modifications, including dehydrated amino acids such as dehydroalanine (Dha) and dehydrobutyrine (Dhb), as well as lanthionine (Lan) and methyllanthionine (MeLan) bridges . The full elucidation of paenibacillin's structure presents challenges, particularly in determining the precise arrangement of thioether bridges and resolving mass ambiguities related to amino acid isomers (Leu/Ile) and isobaric residues (Lys/Gln), as well as identifying the nature of the N-terminal capping . Despite these challenges, researchers have proposed a tentative primary sequence of paenibacillin based on fragmentation analysis, although the complete structural details remain to be fully characterized in future investigations .

What is the antimicrobial spectrum of paenibacillin and how does it compare to other antimicrobials produced by P. polymyxa?

Paenibacillin exhibits a broad antimicrobial spectrum specifically targeting Gram-positive bacteria, which complements the activity of polymyxin E1 (also produced by P. polymyxa OSY-DF) that is effective against Gram-negative bacteria . According to comprehensive testing, paenibacillin demonstrates activity against numerous food-borne pathogenic and spoilage Gram-positive bacteria, including Bacillus cereus, Bacillus subtilis, Clostridium sporogenes, multiple Lactobacillus species (L. acidophilus, L. casei, L. plantarum), Lactococcus lactis, Leuconostoc mesenteroides, Listeria species (L. innocua, L. monocytogenes), Pediococcus cerevisiae, Staphylococcus aureus, and Streptococcus agalactiae . In contrast, paenibacillin shows no activity against Gram-negative bacteria such as Escherichia coli (including O157:H7 strains), Salmonella species, Pseudomonas putida, and Yersinia enterocolitica, which are effectively inhibited by polymyxin E1 . The complementary antimicrobial spectra of paenibacillin and polymyxin E1 make their co-production by P. polymyxa OSY-DF particularly valuable for applications targeting both Gram-positive and Gram-negative bacteria simultaneously . This dual production differs from previously reported P. polymyxa strains, such as P13, which produces a 10 kDa bacteriocin-like peptide called polyxin with activity against both Gram-positive and Gram-negative bacteria, and strain NRRL-B-30509, which produces a class IIa bacteriocin (3,864 Da) effective against Campylobacter species .

What are the optimal methods for isolating and identifying P. polymyxa strains that produce paenibacillin?

The isolation and identification of P. polymyxa strains capable of producing paenibacillin requires a systematic approach combining selective culturing techniques with comprehensive taxonomic characterization. Based on methods used for the isolation of P. polymyxa OSY-DF, researchers should initially screen fermented food samples or environmental sources for microorganisms displaying strong antimicrobial properties . This screening process typically involves preparing agar diffusion assays where potential producer strains are grown against indicator organisms to detect zones of inhibition . Following initial isolation, suspected P. polymyxa strains should undergo morphological examination (including assessment of spore formation), biochemical characterization, and genetic analysis through 16S rRNA gene sequencing . A polyphasic taxonomic approach that integrates phenotypic traits with molecular data provides the most reliable identification, as demonstrated in comprehensive studies of Paenibacillus species . The specific production of paenibacillin can be confirmed through bioassays against Gram-positive bacterial indicators, followed by chromatographic analysis to determine the molecular weight of the antimicrobial compound (approximately 2,983 Da for paenibacillin) . Additionally, researchers should evaluate the strain's ability to concurrently produce polymyxin E1, as this dual production capability is a distinctive characteristic of P. polymyxa OSY-DF and could serve as a marker for identifying similar producer strains .

How can recombinant expression systems be developed for enhanced paenibacillin production?

Developing recombinant expression systems for enhanced paenibacillin production requires first identifying and characterizing the complete biosynthetic gene cluster responsible for paenibacillin synthesis in P. polymyxa OSY-DF. This process should begin with whole genome sequencing, which can be accomplished using a combination of short-read (Illumina) and long-read (Oxford Nanopore) technologies to ensure complete genome assembly, similar to the approach used for other Paenibacillus species . Given that lantibiotics undergo extensive post-translational modifications, the gene cluster should include not only the structural gene encoding the precursor peptide, but also genes encoding modification enzymes responsible for introducing dehydrated amino acids and thioether bridges . Once identified, the biosynthetic gene cluster can be cloned into suitable expression vectors for heterologous expression in host systems such as Escherichia coli, Bacillus subtilis, or other compatible hosts with well-established genetic tools . The expression system should be optimized to ensure proper folding and post-translational modification of the lantibiotic, which may require co-expression of the necessary modification enzymes . Since paenibacillin contains multiple thioether bridges and other modifications, optimization of culture conditions (temperature, pH, nutrient composition) will be crucial for maximizing functional peptide production . Additionally, the expression system should be designed to facilitate efficient purification of the recombinant paenibacillin, potentially incorporating affinity tags that can be removed without affecting the peptide's antimicrobial activity .

What purification strategies are most effective for obtaining high-purity paenibacillin for research purposes?

Obtaining high-purity paenibacillin for research purposes requires a multi-step purification strategy that leverages the physicochemical properties of this lantibiotic. The initial approach, as demonstrated with P. polymyxa OSY-DF, involves adsorption of antimicrobial compounds from the culture supernatant to XAD resin, which effectively captures both paenibacillin and polymyxin E1 in a one-step procedure . Following this initial capture, the separation of paenibacillin from polymyxin E1 and other compounds can be achieved through sequential chromatographic methods, starting with preparative reverse-phase high-performance liquid chromatography (RP-HPLC) using appropriate gradients of water-acetonitrile with trifluoroacetic acid . Further purification can be accomplished using semi-preparative RP-HPLC to achieve single-peak homogeneity, which is essential for subsequent structural analyses and accurate antimicrobial activity testing . The purity of isolated paenibacillin can be confirmed by analytical HPLC, mass spectrometry, and bioassays against sensitive indicator organisms such as Bacillus or Listeria species . Throughout the purification process, it is important to monitor antimicrobial activity to ensure retention of biological function, as some purification steps might affect the peptide's conformation or activity . Additionally, researchers should consider the use of size-exclusion chromatography or ion-exchange chromatography as complementary techniques to achieve higher purity, particularly when preparing samples for detailed structural analyses such as NMR spectroscopy or X-ray crystallography, which require exceptionally pure material .

What analytical techniques are essential for elucidating the complete structure of paenibacillin?

The complete structural elucidation of paenibacillin requires a sophisticated multi-technique approach due to its complex nature as a lantibiotic with extensive post-translational modifications. Edman degradation, which was employed in the initial characterization of paenibacillin, is valuable for N-terminal sequencing but faces limitations with modified residues and becomes blocked when encountering certain modifications . Mass spectrometry (MS) techniques, particularly tandem MS (MS/MS), are crucial for peptide sequencing and identifying the positions of modifications, while advanced approaches like deuterium-labeled Ni2B-based desulfurization/reduction can help resolve structural blockages and generate linear structures suitable for MS/MS sequencing . Nuclear magnetic resonance (NMR) spectroscopy provides essential information about the three-dimensional structure and the arrangement of thioether bridges, which cannot be fully determined by fragmentation analysis alone . To resolve mass ambiguities between amino acid isomers (Leu/Ile) and isobaric residues (Lys/Gln), researchers should employ specialized MS techniques such as high-resolution MS or specific chemical derivatization methods that can differentiate between these residues . Additionally, X-ray crystallography, although challenging with small peptides, could provide definitive structural information if crystals of sufficient quality can be obtained . The integration of data from these complementary techniques, combined with bioinformatic analysis of the biosynthetic gene cluster, is necessary to resolve remaining structural questions, particularly regarding the N-terminal capping and the precise arrangement of thioether bridges in paenibacillin .

How do researchers investigate the mechanism of action of paenibacillin against Gram-positive bacteria?

Investigating the mechanism of action of paenibacillin against Gram-positive bacteria requires a comprehensive approach that examines its interactions with bacterial cell components and resultant physiological effects. Researchers should begin with membrane permeabilization assays using fluorescent dyes (e.g., propidium iodide, SYTOX Green) that enter bacterial cells only when membrane integrity is compromised, allowing real-time monitoring of paenibacillin's effects on membrane permeability . As a lantibiotic, paenibacillin likely targets cell envelope components, so researchers should investigate its binding to specific receptors or precursors involved in cell wall biosynthesis, similar to other lantibiotics like nisin that binds to lipid II . Electrophysiological techniques, such as black lipid membrane experiments, can be employed to determine if paenibacillin forms discrete pores in bacterial membranes or causes non-specific membrane disruption . The specificity of paenibacillin for Gram-positive bacteria suggests interaction with components absent in Gram-negative bacteria, so comparative studies examining its binding and activity against various cell envelope fractions from both bacterial types would provide valuable insights . Additionally, resistance development studies, where bacteria are exposed to sub-lethal concentrations of paenibacillin followed by whole-genome sequencing of resistant mutants, can identify genes associated with susceptibility or resistance, further illuminating the mechanism of action . Structural studies correlating specific regions or modifications of paenibacillin with antimicrobial activity, through the generation and testing of synthetic analogs or modified variants, would establish structure-function relationships essential for understanding its antimicrobial mechanism .

How can the biosynthetic gene cluster for paenibacillin be identified and characterized?

Identifying and characterizing the biosynthetic gene cluster for paenibacillin requires a comprehensive genomic approach combined with functional validation. Researchers should first perform whole-genome sequencing of P. polymyxa OSY-DF using a combination of short-read and long-read sequencing technologies to ensure complete coverage and accurate assembly, similar to approaches used for other Paenibacillus species that achieved full genome closure . The assembled genome can then be analyzed using specialized bioinformatic tools designed for identifying lantibiotic gene clusters, such as antiSMASH, BAGEL, or PRISM, which recognize conserved biosynthetic domains and modification enzymes characteristic of lantibiotics . As a class I lantibiotic, paenibacillin's gene cluster should contain at least a structural gene encoding the precursor peptide (with distinct leader and core peptide regions), genes encoding LanB and LanC enzymes responsible for dehydration and cyclization reactions, respectively, and potentially genes involved in export, immunity, and regulation . To validate candidate gene clusters, researchers should employ techniques such as gene knockout or heterologous expression, followed by LC-MS analysis to confirm the production or absence of paenibacillin . Transcriptional analysis using RNA-seq or quantitative PCR can determine expression patterns of the identified genes under different growth conditions, providing insights into regulatory mechanisms . Additionally, detailed sequence analysis of the structural gene should align with the tentative primary structure determined through chemical analysis, with special attention to residues that undergo post-translational modifications, while comparative genomics with other Paenibacillus species can identify unique features of the paenibacillin biosynthetic pathway .

What genetic engineering approaches can optimize paenibacillin production in native and heterologous hosts?

Optimizing paenibacillin production through genetic engineering requires targeted modifications of both the biosynthetic genes and regulatory elements controlling their expression. In the native P. polymyxa OSY-DF host, researchers should first characterize the natural promoters controlling the paenibacillin gene cluster and replace them with stronger, inducible promoters to increase transcription levels . The structural gene encoding the paenibacillin precursor peptide could be modified to improve translation efficiency through codon optimization and strengthening of the ribosome binding site, while also potentially removing rate-limiting steps in post-translational processing . For heterologous expression in alternative hosts like Bacillus subtilis or Escherichia coli, the entire biosynthetic gene cluster should be cloned and engineered to function efficiently in the new cellular environment, with particular attention to ensuring compatibility of transcriptional, translational, and post-translational modification machinery . Given the complex modifications in lantibiotics, researchers might need to co-express chaperones or modify the host's protein folding machinery to ensure proper formation of thioether bridges and other modifications essential for paenibacillin's antimicrobial activity . Metabolic engineering of precursor supply pathways could further enhance production by ensuring adequate availability of amino acids and energy sources needed for paenibacillin biosynthesis . Additionally, knockout or downregulation of competing metabolic pathways, particularly those related to sporulation or other secondary metabolites, could redirect cellular resources toward paenibacillin production . The development of high-throughput screening systems based on antimicrobial activity or reporter gene fusions would facilitate rapid assessment of genetic modifications and accelerate the optimization process through iterative strain improvement .

How does genomic analysis help understand the evolutionary relationship between paenibacillin and other lantibiotics?

Genomic analysis provides crucial insights into the evolutionary history of paenibacillin and its relationship to other lantibiotics through comparative genomics and phylogenetic approaches. By comparing the paenibacillin biosynthetic gene cluster with those of other characterized lantibiotics, researchers can identify conserved and unique genetic elements that reflect evolutionary relationships and functional specialization . Sequence analysis of the precursor peptide gene can reveal homology with other lantibiotic structural genes, while examination of the modification enzymes can indicate shared ancestry or convergent evolution of biosynthetic machinery . The complete genome sequence of P. polymyxa OSY-DF, when analyzed alongside other Paenibacillus genomes (such as the fully sequenced Paenibacillus sp. RUD330 with its 5.56 Mbp genome and 59% GC content), can provide context for understanding how horizontal gene transfer, gene duplication, or recombination events might have contributed to the acquisition and evolution of the paenibacillin biosynthetic pathway . The unique co-production of paenibacillin (active against Gram-positive bacteria) and polymyxin E1 (active against Gram-negative bacteria) by P. polymyxa OSY-DF raises interesting evolutionary questions about whether this dual production capability arose through independent acquisition events or coordinated evolution under selective pressure for broad-spectrum antimicrobial activity . Comprehensive phylogenetic analysis of lantibiotic-associated genes across diverse bacterial genera can place paenibacillin in the broader evolutionary context of lantibiotics and help identify potential ancestral relationships . Additionally, analysis of genomic islands, mobile genetic elements, and sequence composition (e.g., GC content) within and surrounding the paenibacillin gene cluster can provide evidence of horizontal acquisition and help reconstruct its evolutionary history within the Paenibacillus genus .

What standardized methods should be used for evaluating paenibacillin's antimicrobial efficacy in research settings?

Standardized evaluation of paenibacillin's antimicrobial efficacy requires rigorous methodological approaches that ensure reproducibility and comparability across different research settings. Researchers should employ broth microdilution assays following guidelines established by the Clinical and Laboratory Standards Institute (CLSI) or similar standardizing bodies to determine minimum inhibitory concentrations (MICs) against a panel of relevant Gram-positive bacteria, including reference strains and clinical isolates . The antimicrobial spectrum should be comprehensively assessed against diverse bacterial species similar to the testing performed for P. polymyxa OSY-DF, which demonstrated paenibacillin's activity against Bacillus species, Clostridium sporogenes, Lactobacillus species, Listeria species, and Staphylococcus aureus, among others . Time-kill kinetics studies should be conducted to determine the rate of bacterial killing and whether paenibacillin exhibits bacteriostatic or bactericidal activity, with sampling at standardized time points (e.g., 0, 2, 4, 6, 8, 12, and 24 hours) following exposure . The impact of environmental factors on antimicrobial efficacy should be systematically evaluated by testing activity under various conditions including different pH levels (particularly within the range of pH 2.0-9.0 where paenibacillin demonstrates stability), temperatures, salt concentrations, and in the presence of relevant food components or bodily fluids, depending on the intended application . Additionally, researchers should assess potential development of resistance through serial passage experiments where bacteria are repeatedly exposed to sub-inhibitory concentrations of paenibacillin, with documentation of any changes in MICs over time and characterization of resistant mutants if they emerge .

How can researchers investigate the potential of paenibacillin for controlling antibiotic-resistant Gram-positive pathogens?

Investigating paenibacillin's potential against antibiotic-resistant Gram-positive pathogens requires a systematic evaluation of its efficacy against clinically relevant resistant isolates and an understanding of its mechanisms in comparison to conventional antibiotics. Researchers should assemble a diverse panel of antibiotic-resistant Gram-positive clinical isolates, particularly those displaying resistance to commercially important antibiotics such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and multidrug-resistant Listeria monocytogenes . Activity testing should include determination of MICs against these resistant strains compared to their sensitive counterparts to identify any cross-resistance patterns or potential advantages of paenibacillin over conventional antibiotics . Mechanistic studies comparing paenibacillin's mode of action with those of antibiotics to which these pathogens have developed resistance would provide insights into whether paenibacillin could overcome existing resistance mechanisms . Synergy studies evaluating paenibacillin in combination with conventional antibiotics could reveal potential combinatorial approaches for treating resistant infections, particularly given that paenibacillin's co-production with polymyxin E1 suggests natural synergistic potential . Researchers should also conduct genetic studies to identify potential resistance mechanisms against paenibacillin by exposing resistant pathogens to the lantibiotic and analyzing any adaptive mutations that emerge . Finally, in vitro time-kill studies and potentially in vivo infection models using resistant pathogens would provide crucial data on paenibacillin's efficacy in more complex systems that better approximate clinical scenarios, while also assessing important parameters such as dosing requirements, pharmacokinetics, and potential toxicity issues that would influence its development as a therapeutic agent against resistant pathogens .

What are the considerations for designing experiments to evaluate the stability and bioactivity of paenibacillin under different environmental conditions?

Designing experiments to evaluate paenibacillin's stability and bioactivity under different environmental conditions requires careful consideration of relevant variables and appropriate analytical methods. Researchers should first establish baseline stability profiles by exposing purified paenibacillin to a range of temperatures (refrigeration, room temperature, elevated temperatures up to autoclaving conditions) for varying durations, followed by activity testing and structural analysis to determine thermal stability thresholds . pH stability studies should systematically expose paenibacillin to buffers ranging from pH 2.0 to 9.0 (reflecting its reported stability range) with additional testing beyond these boundaries to define precise pH tolerance limits, with particular attention to conditions relevant to potential applications in food systems or medical settings . The impact of proteolytic enzymes should be evaluated by incubating paenibacillin with digestive enzymes (pepsin, trypsin, chymotrypsin) and proteases from relevant bacteria to assess susceptibility to enzymatic degradation, which has implications for both applications and delivery methods . For food-related applications, researchers should test stability in various food matrices, considering interactions with food components such as proteins, lipids, and carbohydrates that might affect antimicrobial efficacy, along with storage studies under typical food preservation conditions . The effect of ionic strength and specific ions should be evaluated since many lantibiotics are sensitive to cations, particularly divalent ions like Ca2+ and Mg2+, which can interfere with their interaction with bacterial membranes . Additionally, long-term storage stability studies should be conducted under various conditions (lyophilized, in solution, at different temperatures) with periodic testing of antimicrobial activity to establish shelf-life parameters and optimal storage recommendations for maintaining paenibacillin's bioactivity in research and potential application settings .

What are the most promising avenues for advancing our understanding of paenibacillin's structure-function relationships?

Advancing our understanding of paenibacillin's structure-function relationships requires integrated approaches combining structural biology, molecular genetics, and antimicrobial testing. One of the most promising avenues involves the generation of paenibacillin variants through site-directed mutagenesis of the precursor peptide gene, targeting specific residues involved in post-translational modifications, particularly those that form lanthionine (Lan) and methyllanthionine (MeLan) bridges . By systematically altering these residues and assessing the impact on antimicrobial activity, researchers can identify critical structural elements essential for paenibacillin's function . High-resolution structural determination techniques, particularly solution NMR spectroscopy optimized for lantibiotics, would provide detailed three-dimensional structural information beyond what has been achieved through existing methods, helping to resolve the current ambiguities regarding thioether bridge arrangements and N-terminal capping . Computational approaches, including molecular dynamics simulations and docking studies, can model paenibacillin's interactions with bacterial membrane components and potential cellular targets, generating testable hypotheses about its mechanism of action . The development of synthetic or semi-synthetic paenibacillin analogs with systematic structural modifications could create a library of compounds for structure-activity relationship studies, potentially leading to derivatives with enhanced antimicrobial properties or expanded spectrum of activity . Additionally, comparative analysis of paenibacillin with other well-characterized lantibiotics could identify conserved structural motifs associated with specific functions, while heterologous expression systems capable of producing paenibacillin variants would facilitate rapid screening of engineered peptides . These approaches would collectively advance our fundamental understanding of this complex lantibiotic and potentially lead to novel antimicrobial agents based on the paenibacillin scaffold .

How might researchers explore the potential ecological role of paenibacillin in P. polymyxa's natural environment?

Exploring the ecological role of paenibacillin in P. polymyxa's natural environment requires an interdisciplinary approach that examines the compound's function in natural microbial communities. Researchers should begin with habitat characterization studies that identify the natural ecological niches of P. polymyxa OSY-DF, particularly focusing on fermented foods where it was originally isolated, to understand the microbial community composition and potential competitive interactions . Metagenomics and metatranscriptomics analyses of these environments could reveal whether the paenibacillin biosynthetic genes are actively expressed in natural settings and how their expression correlates with environmental factors or the presence of competing microorganisms . Co-culture experiments simulating natural communities could assess how paenibacillin production affects microbial population dynamics, particularly whether it provides a competitive advantage against Gram-positive bacteria while polymyxin E1 targets Gram-negative competitors, potentially explaining the evolutionary advantage of co-producing these complementary antimicrobials . The development of fluorescent reporter strains with paenibacillin biosynthetic genes linked to fluorescent proteins would allow real-time visualization of gene expression in simulated natural environments, providing insights into the spatial and temporal regulation of production . Studies examining paenibacillin production under various environmental stressors (nutrient limitation, pH fluctuations, temperature shifts) could reveal whether it serves as a stress response mechanism or is constitutively produced, while genetic knockout studies comparing the fitness of wild-type and paenibacillin-deficient strains in competitive environments would directly assess its ecological importance . Additionally, researchers should investigate whether paenibacillin plays roles beyond antimicrobial activity, such as in biofilm formation, signaling, or other ecological functions that might explain its evolutionary conservation in P. polymyxa OSY-DF .

What innovative methodological approaches could enhance the detection and quantification of paenibacillin in complex biological samples?

Innovative methodological approaches for enhancing paenibacillin detection and quantification in complex biological samples should leverage recent advances in analytical chemistry and immunological techniques. Researchers could develop liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods with selected reaction monitoring (SRM) or multiple reaction monitoring (MRM) focusing on specific fragment ions unique to paenibacillin, enabling highly sensitive and selective detection even in complex matrices such as food samples, fermentation media, or biological fluids . The development of paenibacillin-specific antibodies through recombinant techniques or by immunizing animals with carrier-conjugated synthetic fragments of the peptide could enable the creation of enzyme-linked immunosorbent assays (ELISAs) or lateral flow immunoassays for rapid field detection without sophisticated instrumentation . Advanced separation techniques such as ultra-high-performance liquid chromatography (UHPLC) coupled with high-resolution mass spectrometry could improve the resolution and sensitivity of paenibacillin detection in complex samples, while ion mobility spectrometry could provide additional separation based on molecular shape, enhancing specificity . Aptamer-based biosensors, developed by selecting oligonucleotides with high affinity for paenibacillin, could offer an alternative approach for specific detection with potentially lower production costs and greater stability compared to antibody-based methods . For real-time monitoring of paenibacillin production in fermentation processes, researchers could develop reporter strains where the paenibacillin promoter drives expression of fluorescent or luminescent proteins, allowing non-destructive monitoring of production dynamics . Additionally, the design of chemical derivatization strategies targeting specific functional groups in paenibacillin could enhance its detection limits by introducing groups that increase ionization efficiency in mass spectrometry or enable fluorescence detection, thereby improving analytical sensitivity in complex samples with potential matrix interference effects .